RS59349B1 - Soli nalmefena kao lekovi za smanjenje konzumiranja alkohola ili za sprečavanje prekomernog konzumiranja alkohola - Google Patents

Soli nalmefena kao lekovi za smanjenje konzumiranja alkohola ili za sprečavanje prekomernog konzumiranja alkohola

Info

Publication number
RS59349B1
RS59349B1 RSP20191242A RS59349B1 RS 59349 B1 RS59349 B1 RS 59349B1 RS P20191242 A RSP20191242 A RS P20191242A RS 59349 B1 RS59349 B1 RS 59349B1
Authority
RS
Serbia
Prior art keywords
alcohol consumption
medicaments
preventing excessive
reducing
nalmefene salts
Prior art date
Application number
Other languages
English (en)
Inventor
Diego Heidi Lopez De
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of RS59349B1 publication Critical patent/RS59349B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
RSP20191242 2013-07-11 2014-07-10 Soli nalmefena kao lekovi za smanjenje konzumiranja alkohola ili za sprečavanje prekomernog konzumiranja alkohola RS59349B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201300421 2013-07-11
PCT/EP2014/064819 WO2015004240A1 (en) 2013-07-11 2014-07-10 Nalmefene salts as medicaments for reducing alcohol consumption or for preventing excessive alcohol consumption
EP14738819.3A EP3019500B1 (en) 2013-07-11 2014-07-10 Nalmefene salts as medicaments for reducing alcohol consumption or for preventing excessive alcohol consumption

Publications (1)

Publication Number Publication Date
RS59349B1 true RS59349B1 (sr) 2019-10-31

Family

ID=51177066

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP20191242 RS59349B1 (sr) 2013-07-11 2014-07-10 Soli nalmefena kao lekovi za smanjenje konzumiranja alkohola ili za sprečavanje prekomernog konzumiranja alkohola

Country Status (27)

Country Link
US (2) US9725458B2 (sr)
EP (1) EP3019500B1 (sr)
JP (1) JP6491653B2 (sr)
KR (1) KR20160030130A (sr)
CN (1) CN105377854B (sr)
AR (1) AR096851A1 (sr)
AU (1) AU2014289182B2 (sr)
CA (1) CA2917576C (sr)
CL (1) CL2015003736A1 (sr)
CY (1) CY1122099T1 (sr)
DK (1) DK3019500T3 (sr)
EA (1) EA031747B1 (sr)
ES (1) ES2749614T3 (sr)
HR (1) HRP20191764T1 (sr)
HU (1) HUE046904T2 (sr)
IL (1) IL243243B (sr)
LT (1) LT3019500T (sr)
ME (1) ME03504B (sr)
MX (1) MX2016000006A (sr)
PH (1) PH12016500052B1 (sr)
PL (1) PL3019500T3 (sr)
PT (1) PT3019500T (sr)
RS (1) RS59349B1 (sr)
SG (1) SG11201600116VA (sr)
SI (1) SI3019500T1 (sr)
TW (1) TW201536288A (sr)
WO (1) WO2015004240A1 (sr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR096851A1 (es) 2013-07-11 2016-02-03 H Lundbeck As Sales que no forman hidratos ni solvatos de nalmefeno

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196376B (en) * 1985-05-23 1988-11-28 Sandoz Ag Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds
HUP0401022A3 (en) 2001-08-14 2006-11-28 Biotie Therapies Corp Method for the preparation of pharmaceutical compositions containing opioid antagonist for treating alcoholism or alcohol abuse
ES2377599T3 (es) * 2008-04-24 2012-03-29 Janssen Pharmaceutica N.V. Profármacos di-éster de nalmefeno
GB0814043D0 (en) * 2008-07-31 2008-09-10 Serentis Ltd The treatment of skin disorders
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
SI2435439T1 (sl) 2009-05-25 2016-06-30 H. Lundbeck A/S Priprava nalmefen hidroklorida iz naltreksona
MX2013005009A (es) 2010-11-05 2013-08-01 Lundbeck & Co As H Metodo para la elaboracion de naltrexona.
CN103012416B (zh) 2011-09-28 2015-07-01 辽宁海思科制药有限公司 一种盐酸纳美芬的制备方法
AR096851A1 (es) 2013-07-11 2016-02-03 H Lundbeck As Sales que no forman hidratos ni solvatos de nalmefeno

Also Published As

Publication number Publication date
AU2014289182A1 (en) 2016-01-21
TW201536288A (zh) 2015-10-01
HUE046904T2 (hu) 2020-03-30
LT3019500T (lt) 2019-10-25
WO2015004240A1 (en) 2015-01-15
CN105377854A (zh) 2016-03-02
HRP20191764T1 (hr) 2019-12-27
JP2016523949A (ja) 2016-08-12
US9725458B2 (en) 2017-08-08
ME03504B (me) 2020-04-20
PH12016500052A1 (en) 2016-03-28
EP3019500A1 (en) 2016-05-18
IL243243B (en) 2018-12-31
PL3019500T3 (pl) 2020-01-31
AR096851A1 (es) 2016-02-03
AU2014289182B2 (en) 2018-02-22
CA2917576C (en) 2022-05-31
US9938286B2 (en) 2018-04-10
PT3019500T (pt) 2019-10-25
EA031747B1 (ru) 2019-02-28
CN105377854B (zh) 2018-08-31
EA201592228A1 (ru) 2016-05-31
US20170275294A1 (en) 2017-09-28
CL2015003736A1 (es) 2016-08-19
MX2016000006A (es) 2016-03-09
CY1122099T1 (el) 2020-11-25
US20160152625A1 (en) 2016-06-02
CA2917576A1 (en) 2015-01-15
EP3019500B1 (en) 2019-09-11
PH12016500052B1 (en) 2016-03-28
KR20160030130A (ko) 2016-03-16
SG11201600116VA (en) 2016-02-26
ES2749614T3 (es) 2020-03-23
SI3019500T1 (sl) 2019-11-29
NZ715200A (en) 2021-02-26
JP6491653B2 (ja) 2019-03-27
DK3019500T3 (da) 2019-10-14

Similar Documents

Publication Publication Date Title
HK1215795A1 (zh) 鵝膏毒素衍生物
HK1220382A1 (zh) 用於保護皮膚的化合物
PT2953944T (pt) Derivados de piridazinona-amidas
HK1226347A1 (zh) Aramchol鹽
HK1211578A1 (en) Amidoimidazopyridazines as mknk-1 kinase inhibitors mknk-1
GB201314217D0 (en) Coolant purification
EP2941292A4 (en) SLEEP IMPROVEMENT SYSTEMS
LT3027598T (lt) Oksochinazolinil-butanamido dariniai
HK1220443A1 (zh) 用作止痛藥的全氫喹喔啉衍生物
PT3087076T (pt) Derivados de imidazopirazinona
HK1217652A1 (zh) 水性組合物
EP2970642A4 (en) REFRESHING AGENTS
PL2757142T3 (pl) Kompozycja zmniejszająca opór
IL243243B (en) Nalampen salts as a drug to reduce alcohol consumption or to prevent excessive alcohol consumption
LT2883541T (lt) Kompozicija, apimanti hialurono rūgštį, skirta vietiniam naudojimui
GB2515553B (en) Coolant purification
TWM476292U (en) Power-saving system
GB201200417D0 (en) Sleep system
GB201300087D0 (en) Dram